TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive NCI To Fund Only 30-35% Of Approved Grants Even With $815 Million Construction Slashed August 20, 1976
TCL Archive Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research September 7, 1984
TCL Archive Cooperative Groups: Insurers Agree To Cover Patient Care Costs In Group Trials September 26, 1997
